Lucence attracts $20M in series A to scale up operations Nov. 26, 2019 By Jihyun Kim No Comments HONG KONG – Lucence Diagnostics Pte Ltd., a genomic medicine company headquartered in Singapore, has secured $20 million in series A investment.Read More
Lucence attracts $20M in series A to scale up operations Nov. 21, 2019 By Jihyun Kim No Comments HONG KONG – Lucence Diagnostics Pte Ltd., a genomic medicine company headquartered in Singapore, has secured $20 million in series A investment. The company is focused on inventing liquid biopsy tests for cancer screening and personalizing care. Read More